Fig. 2From: Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinomaGenetic mutation and drug sensitivity of RFXs in STAD. (A-B) Single nucleotide variants of RFXs in STAD. (C) Copy number variation of RFXs in STAD. (D) Spearman's correlation analysis of the sensitivity of RFXs to drugs. STAD, stomach adenocarcinomaBack to article page